Parlex to manufacture NeuroMetrix' biosensors for diagnosing neuropathies:
This article was originally published in Clinica
Executive Summary
NeuroMetrix has formalised its partnership with Parlex US, the Johnson Electric division specialising in flexible interconnect products, by awarding the latter with mutually exclusive agreement to manufacture biosensors used to diagnose neuropathies. Waltham, Massachusetts-based NeuroMetrix' NC-stat system, launched in 1999, is designed to diagnose diseases of the peripheral nerves and parts of the spine that are linked to clinical disorders such as diabetes, low back pain and carpal tunnel syndrome.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.